Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.
- DOI
- 10.1038/s41386-026-02468-1
- Published
- 2026 Jun 21
- Container
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41386-026-02468-1,
title = {Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.},
author = {John MM and Gale JJ and Yaeger JDW and Gerberding HA and Meyer LS and Legner GL and Cox BS and Brummels RA and Segar SM and Summers CH},
year = {2026},
journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
doi = {10.1038/s41386-026-02468-1},
url = {https://doi.org/10.1038/s41386-026-02468-1}
}RIS
TY - JOUR TI - Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes. AU - John MM AU - Gale JJ AU - Yaeger JDW AU - Gerberding HA AU - Meyer LS AU - Legner GL AU - Cox BS AU - Brummels RA AU - Segar SM AU - Summers CH PY - 2026 JO - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology DO - 10.1038/s41386-026-02468-1 UR - https://doi.org/10.1038/s41386-026-02468-1 ER -
APA
MM, J., JJ, G., JDW, Y., HA, G., LS, M., GL, L., BS, C., RA, B., SM, S., & CH, S. (2026). Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02468-1
Source records
- pubmed · retrieved 2026-09-26T10:35:32.949Z